FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $60,000 | – | 10,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $21,256,962 | 14.19% |
| Solas Capital Management, LLC | 1,439,028 | $12,706,617 | 8.46% |
| DG Capital Management, LLC | 1,074,654 | $9,489,195 | 4.23% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $4,122,453 | 2.31% |
| AIGH Capital Management LLC | 349,457 | $3,085,705 | 1.26% |
| APIS CAPITAL ADVISORS, LLC | 90,000 | $794,700 | 0.80% |
| Southpoint Capital Advisors LP | 4,077,214 | $36,001,800 | 0.78% |
| Worth Venture Partners, LLC | 93,252 | $823,415 | 0.45% |
| Lion Point Capital, LP | 110,000 | $971,300 | 0.44% |
| GENDELL JEFFREY L | 283,413 | $2,502,537 | 0.19% |